Workflow
Globe Life(GL)
icon
Search documents
Globe Life Announces New Share Repurchase Authorization
Prnewswire· 2024-11-18 12:00
MCKINNEY, Texas, Nov. 18, 2024 /PRNewswire/ -- Globe Life Inc. (NYSE:GL) announced that its Board of Directors has approved an authorization to repurchase up to $1.8 billion of common stock under the Company's existing stock repurchase program. This authorization has no set time period and replaces the previous authorization of $1.3 billion announced on April 29, 2024. "We are pleased to announce this new authorization, which demonstrates the Board's well-founded confidence in our business model. Our insura ...
Globe Life Q3 Earnings Beat, Revenues Miss, Premiums Rise Y/Y
ZACKS· 2024-10-24 15:50
Globe Life Inc.’s (GL) third-quarter 2024 net operating income of $3.49 per share beat the Zacks Consensus Estimate by 14.4%. The bottom line improved 29% year over year, primarily driven by higher excess investment income and insurance underwriting income.Behind the HeadlinesGlobe Life reported total premium revenues of $1.2 billion, up 5% year over year. This upside was primarily driven by higher premiums from Life and Health insurance.Net investment income increased 7% year over year to $284.9 million.Th ...
Globe Life (GL) Reports Q3 Earnings: What Key Metrics Have to Say
ZACKS· 2024-10-23 23:36
Globe Life (GL) reported $1.46 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 5.1%. EPS of $3.49 for the same period compares to $2.71 a year ago.The reported revenue represents a surprise of -0.66% over the Zacks Consensus Estimate of $1.47 billion. With the consensus EPS estimate being $3.05, the EPS surprise was +14.43%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...
Globe Life (GL) Q3 Earnings Surpass Estimates
ZACKS· 2024-10-23 22:30
Globe Life (GL) came out with quarterly earnings of $3.49 per share, beating the Zacks Consensus Estimate of $3.05 per share. This compares to earnings of $2.71 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.43%. A quarter ago, it was expected that this life and health insurance company would post earnings of $2.90 per share when it actually produced earnings of $2.97, delivering a surprise of 2.41%.Over the last four quar ...
Globe Life(GL) - 2024 Q3 - Quarterly Results
2024-10-23 20:41
GLOBE LIFE INC. REPORTS Third Quarter 2024 Results McKinney, TX, October 23, 2024—Globe Life Inc. (NYSE: GL) reported today that for the quarter ended September 30, 2024, net income was $3.44 per diluted common share, compared with $2.68 per diluted common share for the year-ago quarter. Net operating income for the quarter was $3.49 per diluted common share, compared with $2.71 per diluted common share for the year-ago quarter. HIGHLIGHTS: l Net income as an ROE was 22.4% for the nine months ended Septembe ...
Insights Into Globe Life (GL) Q3: Wall Street Projections for Key Metrics
ZACKS· 2024-10-21 14:21
In its upcoming report, Globe Life (GL) is predicted by Wall Street analysts to post quarterly earnings of $3.05 per share, reflecting an increase of 12.6% compared to the same period last year. Revenues are forecasted to be $1.47 billion, representing a year-over-year increase of 5.8%.The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during ...
Globe Life (GL) Reports Next Week: Wall Street Expects Earnings Growth
ZACKS· 2024-10-16 15:06
Core Viewpoint - Globe Life (GL) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with the actual results being a significant factor influencing its near-term stock price [1][2]. Earnings Expectations - The earnings report is scheduled for October 23, 2024, with expectations that better-than-expected key numbers could lead to a stock price increase, while missing estimates may result in a decline [2]. - The consensus estimate for Globe Life's quarterly earnings is $3.05 per share, reflecting a year-over-year increase of +12.6%, with revenues projected at $1.47 billion, up 5.8% from the previous year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised down by 0.11%, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for Globe Life is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +0.25%, suggesting a bullish outlook from analysts [10]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive Earnings ESP reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - Globe Life currently holds a Zacks Rank of 3, indicating a likelihood of beating the consensus EPS estimate [10]. Historical Performance - In the last reported quarter, Globe Life exceeded the expected earnings of $2.90 per share by delivering $2.97, resulting in a surprise of +2.41% [11]. - Over the past four quarters, Globe Life has surpassed consensus EPS estimates three times [12]. Industry Context - Moody's (MCO), a peer in the Zacks Financial - Miscellaneous Services industry, is expected to report earnings of $2.75 per share for the same quarter, reflecting a year-over-year change of +13.2%, with revenues projected at $1.69 billion, up 14.6% [16]. - Moody's has seen a 1.5% upward revision in its consensus EPS estimate over the last 30 days, resulting in a positive Earnings ESP of 7.57% and a Zacks Rank of 2 (Buy), indicating a strong likelihood of beating the consensus EPS estimate [17].
Globe Life Banks on Solid Segmental Growth Amid Cost Woes
ZACKS· 2024-10-11 16:01
Company Overview - Globe Life Inc. (GL) is positioned to benefit from increased life and health sales, improved invested assets, higher productivity and agent count, strong liquidity, and effective capital deployment [1] - The company has experienced a positive revenue trend driven by premium growth in its Life Insurance and Health Insurance segments, as well as net investment income [1] Future Growth Drivers - The American Income and Liberty National divisions are expected to drive future revenue growth, with Liberty National benefiting from improved productivity and agent count [2] - Globe Life's expansion initiatives in densely populated and less penetrated areas are anticipated to contribute to future growth [2] - Net life and health sales for Liberty National are projected to grow in the mid-teens percentage range [2] Investment Income - Net investment income is a crucial driver of the company's top-line growth and has shown improvement over recent years [3] - This metric is expected to continue growing due to enhanced invested assets and higher interest rates on new investments [3] Financial Position - Globe Life maintains a strong liquidity position with robust cash-generation capabilities from its life and health insurance operations [4] - The company has set a target for a consolidated Company Action Level RBC ratio of 300-320% for 2024 [4] Capital Management - A strong capital position allows Globe Life to enhance shareholder value through share buybacks and dividend payouts [5] - The company has consistently increased its dividend over the past eight years (2016-2023) at a compound annual growth rate (CAGR) of 6.79% [5] Expense Management - Globe Life has faced rising expenses in recent years, including higher policyholder benefits, amortization of deferred acquisition costs, and administrative expenses [6] - For 2024, administrative expenses are expected to be approximately 7% of premiums, which is an increase from 2023 levels [6] Debt Levels - The company's long-term debt has been increasing, with a deterioration in the debt-to-capital ratio [7] - As of June 30, 2024, total debt rose by 11% year over year, leading to higher interest expenses [7]
Here's Why Globe Life (GL) is a Strong Momentum Stock
ZACKS· 2024-09-23 14:51
Company Overview - Globe Life Inc. is an insurance holding company based in McKinney, TX, founded in 1979, primarily marketing individual life and supplemental health insurance to lower-middle to middle-income households in the United States [11] - The company offers a variety of nonparticipating ordinary life insurance products, including traditional whole life, term life, and supplemental health insurance products such as Medicare Supplement and critical illness plans [11] Investment Ratings - Globe Life is currently rated 3 (Hold) on the Zacks Rank, with a VGM Score of B, indicating a moderate investment potential [12] - The company has a Momentum Style Score of B, with shares increasing by 5.4% over the past four weeks [12] Earnings Estimates - For fiscal 2024, six analysts have revised their earnings estimates upwards in the last 60 days, with the Zacks Consensus Estimate increasing by $0.18 to $11.93 per share [12] - Globe Life has an average earnings surprise of 1.5%, suggesting a positive trend in earnings performance [12] Investment Considerations - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Globe Life is recommended for investors looking for potential opportunities in the finance sector [13]
GL Stock Plunges 16.7% Year to Date: Should You Hold or Fold?
ZACKS· 2024-09-12 13:20
Core Viewpoint - Globe Life Inc. has faced significant challenges in 2023, with a 16.7% decline in share price year-to-date, underperforming both the finance sector and the broader market, despite positive growth projections for earnings and revenues in the coming years [1][6][15] Financial Performance - Globe Life's shares have decreased by 16.7% in 2023, while the finance sector and S&P 500 have seen returns of 12% and 15%, respectively [1] - The company has been struggling with rising expenses, including policyholder benefits, acquisition costs, and interest expenses, leading to an increase in total expenses [2] - Administrative expenses are projected to be around 7% of premiums in 2024, which is an increase from 2023 levels [3] Debt and Capital Structure - Globe Life's long-term debt has risen, with a debt-to-capital ratio worsening; total debt increased by 11% year-over-year as of June 30, 2024 [4] - The company faces higher interest expenses due to its elevated debt levels, which could impact its creditworthiness if not managed properly [4] Stock Performance and Technical Analysis - The stock closed at $101.34, above its 50-day simple moving average of $93.43, indicating a potential uptrend [5] Growth Projections - The Zacks Consensus Estimate predicts a 12% year-over-year increase in earnings per share for 2024, with revenues expected to reach $5.82 billion, reflecting a 5.5% improvement [6] - For 2025, earnings per share and revenues are projected to grow by 10.6% and 4.7%, respectively, compared to 2024 estimates [6] Analyst Sentiment - Recent analyst activity shows one analyst has raised 2024 estimates, while two have increased 2025 estimates, indicating a slight positive sentiment [7] Return on Capital - Globe Life's trailing 12-month return on equity stands at 21.9%, surpassing the industry average of 20.9%, indicating effective utilization of shareholder funds [7] - The return on invested capital (ROIC) is 13.3%, significantly higher than the industry average of 4.6%, reflecting improved efficiency in generating income [8] Revenue Drivers - Revenue growth is being driven by premium increases in the Life Insurance and Health Insurance segments, as well as net investment income [9] - Strong performance from the American Income and Liberty National divisions is expected to contribute positively to future revenue growth [10] - Net investment income has shown improvement and is anticipated to continue growing due to better invested assets and higher interest rates [11] Liquidity and Capital Position - Globe Life maintains a strong liquidity position with robust cash generation capabilities, targeting a consolidated Company Action Level RBC ratio of 300-320% for 2024 [12] Shareholder Value - The company has a strong capital position, allowing for share buybacks and dividend payouts, with dividends increasing at a CAGR of 6.79% over the past eight years [13] Valuation - Globe Life is trading at a discount compared to the industry average, with a forward 12-month price-to-book ratio of 7.91X, lower than the industry average of 13.54X, presenting a compelling investment opportunity [14] Conclusion - Despite facing higher expenses, Globe Life's growth in life and health sales, improved investment assets, strong liquidity, and effective capital deployment suggest potential for recovery and sustained growth, making it a stock worth holding [15]